Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (291-300 of 397) with videos related to

Pageof 40
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2021
Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteriaJ J Gao, D Krol, P Narayan, et al.
Nature Communications|January 10, 2017
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1Tongzheng Liu, Jia Yu, Min Deng, et al.
Breast Cancer Research and Treatment|May 20, 2023
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2019
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast CancerMothaffar F Rimawi, Polly Niravath, Tao Wang, et al.
Cancer|October 16, 2012
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trialMatthew R Callstrom, Damian E Dupuy, Stephen B Solomon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2022
Corrigendum to "Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria": [Annals of Oncology 32 (2021) 950-953]J J Gao, D Krol, P Narayan, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancerShani Paluch-Shimon, Patrick Neven, Jens Huober, et al.
JCI Insight|July 24, 2020
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole actionJunmei Cairns, James N Ingle, Tanda M Dudenkov, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Pharmacogenetics and Genomics|July 11, 2020
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancerJames N Ingle, Krishna R Kalari, Poulami Barman, et al.
Pageof 40

Showing results (291-300 of 397) with videos related to

Sort By:
Pageof 40
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2021
Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteriaJ J Gao, D Krol, P Narayan, et al.
Nature Communications|January 10, 2017
CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1Tongzheng Liu, Jia Yu, Min Deng, et al.
Breast Cancer Research and Treatment|May 20, 2023
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breastUtsav Joshi, Pravash Budhathoki, Suman Gaire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2019
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast CancerMothaffar F Rimawi, Polly Niravath, Tao Wang, et al.
Cancer|October 16, 2012
Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trialMatthew R Callstrom, Damian E Dupuy, Stephen B Solomon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2022
Corrigendum to "Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria": [Annals of Oncology 32 (2021) 950-953]J J Gao, D Krol, P Narayan, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancerShani Paluch-Shimon, Patrick Neven, Jens Huober, et al.
JCI Insight|July 24, 2020
Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole actionJunmei Cairns, James N Ingle, Tanda M Dudenkov, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Pharmacogenetics and Genomics|July 11, 2020
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancerJames N Ingle, Krishna R Kalari, Poulami Barman, et al.
Pageof 40